Another CDEX/ValiMed pilot site in the news
forbes.com
Jon Huntsman, chairman of chemical company Huntsman Corp. (nyse: HUN - news - people ) and a noted philanthropist, agrees. "I think we'll see more people of wealth plan their estates around charitable giving," says Huntsman, who controls about $500 million in donations for cancer, homelessness and education scholarships through the Jon and Karen Huntsman Foundation and the Huntsman Cancer Foundation.
huntsmancancerfoundation.org
cdex-inc.com
University of Utah Health Sciences Center
Addresses Narcotics Diversion
ValiMed system meets JCAHO and ASHP Standards by validating
return of controlled substances from the operating room.
“The success of the implementation proved the value of the device,” said Jorgenson. “It also got us thinking about other ways it could help us. We are launching another CDEX pilot in the pharmacy at the University of Utah’s Huntsman Cancer Institute to provide additional assurance that our compounded chemotherapy injections are correct. Putting medication validation at the front end will help us eliminate medication error.”
“Looking forward, we expect to expand the use of ValiMed to all of our OR and oncology pharmacies,” added Jorgenson. ‘We are also interested in working with CDEX as they develop additional uses for their ValiMed products.”
Jorgenson noted that using ValiMed for pre-administration drug validation may require additional testing to comply with applicable FDA and other legal requirements.
= = = = = = =
Regarding Mr. Jorgenson's note about pre-administration drug validation...based upon the multiple pre-administration devices ValiMed demonstrated at the December ASHP event, and the subsequent interest generated, I would guess that any news on this would be significant. The FDA was at the event, and Baxa has an interesting history involving... well, let me just say I think this class (or classes) of ValiMed devices offer very significant potential for my investment. |
